Declining China Dat...
Health Care: Health Services
Genomic Health Inc. (GHDX: NASDAQ)
$37.00 -0.38 | -1.02%
05/23/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:177.33
Price Earnings Comparisons:
| GHDX | Sector Avg. | S&P 500 |
|---|---|---|
| 177.33 | 186.20 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 33.52 | 14.17 | 150.10 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 14.10 | 0.57 | 0.16 |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | -1.82 | 0.00 |
Earnings for GHDX:
| EBITDA | 13.91M |
| REVENUE | 235.17M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.08 | $0.00 | $-0.06 | $0.28 |
| Number of Analysts | 8 | 7 | 10 | 9 |
| High Estimate | $-0.03 | $0.04 | $0.03 | $1.14 |
| Low Estimate | $-0.10 | $-0.03 | $-0.15 | $-0.05 |
| Prior Year | $0.08 | $0.11 | $0.28 | $-0.06 |
| Growth Rate (Year over Year) | -193.75% | -98.70% | -121.07% | 568.93% |
Portfolios with GHDX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
Latest GHDX Headlines from TheStreet
- Top Insider Trades: DXM, SPB, AMTD, GHDX 05.17.13 | 08:05 am
- 5 Stocks Insiders Love Right Now 05.15.13 | 12:05 pm
- Top Insider Trades: GHDX WES GGP X 05.15.13 | 09:05 am
- Tech That Disrupts Our Lives for the Better 05.10.13 | 02:05 pm
- GHDX Crosses Above Key Moving Average Level 05.02.13 | 04:05 pm
- 4 Stocks Rising on Unusual Volume 03.29.13 | 07:03 am
- Top Insider Trades: GHDX, CLMS, IRM, FAST 02.22.13 | 09:02 am
- 5 Stocks With Big Insider Buying 02.13.13 | 12:02 pm
- 5 Stocks Poised for Breakouts 01.04.13 | 01:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
Press Releases for GHDX
- Genomic Health Announces Ten Studies Covering Breast, Colon And Prostate Cancers Accepted For Presentation At The American Society Of Clinical Oncology (ASCO) Annual Meeting - PR Newswire 05.21.13 | 08:05 am
- Genomic Health Announces Medicare Expanded Coverage Policy For Oncotype DX® Breast Cancer Test To Include Ductal Carcinoma In Situ (DCIS) Diagnosis - PR Newswire 05.10.13 | 04:05 pm
- Genomic Health Announces Availability Of Oncotype DX® Prostate Cancer Test With Potential To Triple The Number Of Patients Who Can Confidently Choose Active Surveillance And Avoid Side Effects Of Invasive Treatments - PR Newswire 05.08.13 | 08:05 am
- Genomic Health Announces Availability Of Oncotype DX® Prostate Cancer Test With Potential To Triple The Number Of Patients Who Can Confidently Choose Active Surveillance And Avoid Side Effects Of Invasive Treatments - PR Newswire 05.08.13 | 12:05 am
- Genomic Health To Present At Bank Of America Merrill Lynch Health Care Conference - PR Newswire 05.07.13 | 04:05 pm
- Genomic Health And ECOG-ACRIN Cancer Research Group Announce Publication Of Positive DCIS Validation Study In The Journal Of The National Cancer Institute - PR Newswire 05.02.13 | 04:05 pm
- Genomic Health Announces Investor Webcast And Conference Call To Review Positive Clinical Validation And Development Of The Oncotype DX® Prostate Cancer Test On Wednesday, May 8, 2013 - PR Newswire 05.01.13 | 04:05 pm
- Genomic Health To Announce First Quarter 2013 Financial Results And Host Conference Call On Thursday, May 2, 2013 - PR Newswire 04.25.13 | 08:04 am
- Genomic Health Announces Publication Of Second Positive Validation Of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers - PR Newswire 04.17.13 | 08:04 am
- Genomic Health To Address One Of The Most Significant Needs In Men's Health With The Oncotype DX® Prostate Cancer Test - PR Newswire 04.03.13 | 08:04 am
Partner Headlines for GHDX
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying - Benzinga 05.18.13 | 03:05 pm
- Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test - Benzinga 05.10.13 | 04:05 pm
- Genomic Health Earnings: Here’s Why the Stock is Down Now - Wall St. Cheat Sheet 05.02.13 | 08:05 am
- Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 09.12.12 | 03:09 pm
- Cepheid Remains Neutral - Analyst Blog - NASDAQ 08.22.12 | 06:08 pm
- Agilent Wins Patent in US - Analyst Blog - NASDAQ 08.21.12 | 07:08 pm
- Genomic Health Back to Neutral - Analyst Blog - NASDAQ 08.20.12 | 11:08 pm
- Genomic Health Beats on EPS - Analyst Blog - Zacks 08.09.12 | 10:08 am
- CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares - GuruFocus 07.13.12 | 02:07 pm
- Medical Sector Shows Muscle With SXC Health, Cerner - Investor's Business Daily 06.21.12 | 06:06 pm
